期刊文献+

冠心病冠状动脉支架置入术住院死亡33例分析 被引量:3

Retrospective study of 33 deaths of in-patients with percutaneous coronary intervention
原文传递
导出
摘要 目的探讨分析冠状动脉支架置入术治疗中住院死亡病因。方法1994-012004-03对广东省人民医院的3252例冠心病病人,行冠状动脉支架置入术治疗术中及术后33例住院死亡患者作回顾性分析。结果其中4例死于术中,其余29例患者死于术后,主要死亡原因依次为:心源性休克、室颤、急性左心衰、多器官衰竭、心脏破裂、急性肾衰,住院病死率为1·01%。结论冠心病冠状动脉支架置入术死亡主要原因是心源性休克、室颤、急性左心衰等。通过一些措施,可以进一步降低住院患者病死率。 Objective To discuss the reasons of death in the in - patients with pemutaneous coronary intervention (PCI). Methods Retrospective analysis was done in 33 cases who died in or after the procedures among 3 252 in - patients with PCI. Results 4 patients died in procedures and the others died after procedures. The major reasons of death in order were : cardiogenic shock, ventrlcular fibrillation, acute left heart failure, multiple organ failure, heart rupture and acute renal failure. The in - hospital mortality rate was 1.01%. Conclusion The major reasons of death of patients with PCI are cardiogenic shock, ventricular fibrillation and acute left heart failure. Taking some measures will reduce the inhospital mortality rate.
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2005年第11期997-999,共3页 Chinese Journal of Practical Internal Medicine
关键词 支架置入术 并发症 死亡 病因 Percutaneous coronary intervention (PCI) Complication Death Etiology
  • 相关文献

参考文献6

二级参考文献17

  • 1Storri S, Santoni T, Minunni M, et al. Surface modifications for the development of piezoimmunosensors[J]. Biosens Bioelectron, 1998,13(3-4): 347-357.
  • 2Guder WG, Ivandic M, Hofmann W, et al. Physiopathology of proteinuria and laboratory diagnostic strategy based on single protein analysis[J]. Clin Chem Lab Med, 1998,36(2) :935-939.
  • 3Hiratsuka N, et al. Analysis of urinary albumin, tranferrin,Nacrtyl beta Dglucosaminidase and beta 2 microglobuin in patients with impaired glucose tolerance[J]. J Clin Lab Anal, 1998,12(6): 351-355.
  • 4Hong CY, Chia KS. Markers of diabetic rephropathy[J]. J Diabetes Complications, 1998,12(1): 43-60.
  • 5Gejyo F, Suzuki S, Arakaua M, et al. Dialysis-related anyloidasis and clinical significance of extracorporeal removal of beta 2 microglibulin[J]. Ther Apher, 1997, 1 (12): 126-128.
  • 6Aviles A, Diaz NR, Neri N, et al. Angiocontric nasal T/natural killer cell lymphoma:a single centre study of prognostic factors in 108 patients[J]. Clin Lab Haematol,2000,22(4) :215-220.
  • 7Idasiak Piechocka J, Krzymanski M, et al. The role of tubulointerstitial changes in progression of kidney function failure in patients with chromic glomerulonephritis [J].Przegl lek,1996,53(5) :443-453.
  • 8Monaco HL. The transthyretin retinol binding protein complex[J]. Biochim Biophys Acta, 2000, 1482 (1-2): 65-72.
  • 9Matsuura K, Ikoma S, Watanabe M, et al. Some Bence Jones proteins enter cultured renal tubular cells, reach nuclei and induc cell death[J]. Immunology, 1999, 98(4):584-589.
  • 10Guan S. Inhibition of Na-K-ATPase activity and gene expression by myeloma light chain in proximal tubule celles[J]. J Investig Med,1999,47(9) :496-501.

共引文献125

同被引文献38

  • 1唐振旺,邓孟球,谭小进,文红艳,廖端芳.566例冠心病患者介入治疗并发症的原因及处理[J].中国动脉硬化杂志,2008,16(12):977-980. 被引量:13
  • 2韩雅玲,梁明,荆全民,王守力,马颖艳,栾波.52例冠状动脉支架内血栓形成患者的临床特点及介入治疗[J].中华心血管病杂志,2006,34(11):975-978. 被引量:34
  • 3Reeder GS,Holmes DR,Lennon RJ,et al.Pmteinuria,serum creatinine,and outcome of percutaneous coronary intervention in patients with diabetes mellitus[J].Am J Cardiol,2002,89:760-764.
  • 4Ledru F,Ducimetiere P,Battaglia S,et al.New diagnestic criteria for diabetes and coronary artery disease:insishts from an angiographic study[J].J Am Coll Cardiol,2001,37:1543-1550.
  • 5Goraya TY,Leibson CL,Palumbo PJ,et al.Coronary atherosclerosis in diabetes mellitus:a population based autopsy study[J].J Am Coll Cardiol,2002,40:946-953.
  • 6Lee CD,Folsom AR,Pankow JS,et al.Atherosclersesis Risk in Communities(ARIC)Study Investigators.Cardiovascular events in diabetic and nondiabetic adults with or without history of myocardial infarction[J].Circulation,2004,109:855-860.
  • 7Haffner SM,Lehto S,Ronnemaa.T,et al.Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction[J].N Ensl J Med,1998,339:229-234.
  • 8Woodfield SL,Lundergan CF,Reiner JS,et al.GUSTO-1 Angiographic Investigators.Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction:the GUSTO-1 experience[J].J Am Coll Cardiol,1996,28:1661-1669.
  • 9Kugelmass AD,Cohen DJ,Houser F,et al.The influence of diabetes mellitus on the practice and outcomes of percutanoous coronary intervention in the community:a report from the HCA database[J].J Invas Cardiol,2003,15:568-574.
  • 10Carson JL,Scholz PM,Chen AY,et al.Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery[J].J Am Coll Cardiol,2002,40:418-423.

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部